Furthermore, TSP2 did not affect the prognosis of patients with stage I and II GC (P > 0.05) but significantly affected the prognosis of patients with stage III and IV GC (P < 0.01), as shown in Table 1. This evidence concerns the gene THBS2 and gastric cancer.